Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)
Journal article published in 2019 by
Javier Puente 
,
Aranzazu González-Del-Alba ,
Núria Sala-Gonzalez,
María José Méndez-Vidal,
Alvaro Pinto,
Ángel Rodríguez,
José Miguel Cuevas Sanz,
Jacobo Rodrigo Muñoz del Toro,
Eduardo Useros Rodríguez,
Ángela García García-Porrero,
Sergio Vázquez
,
Aranzazu González-Del-Alba ,
Núria Sala-Gonzalez,
María José Méndez-Vidal,
Alvaro Pinto,
Ángel Rodríguez,
José Miguel Cuevas Sanz,
Jacobo Rodrigo Muñoz del Toro,
Eduardo Useros Rodríguez,
Ángela García García-Porrero,
Sergio Vázquez
This paper is made freely available by the publisher.
Full text: Download
Data provided by 